[ad_1]
Feb 23 (Reuters) – The World Health Organization (WHO) on
Wednesday said it has set up a hub in South Korea to train low-
and middle-income countries to produce their own vaccines and
therapies and is expanding its COVID-19 vaccine project to
further five nations.
The new training hub comes after the U.N. agency set up a
technology transfer hub in Cape Town, South Africa, last year to
give companies from poor and middle-income countries the
know-how to produce COVID-19 vaccines based on mRNA technology.
The new hub will provide workforce training to all countries
wishing to produce products such as vaccines, insulin,
monoclonal antibodies, the WHO director general Tedros Adhanom
Ghebreyesus said during a press briefing.
The WHO also said five more countries – Bangladesh,
Indonesia, Pakistan, Serbia and Vietnam – will receive support
from its mRNA technology transfer hub in South Africa.
Last week, six African countries – Egypt, Kenya, Nigeria,
Senegal, South Africa and Tunisia – signed up as the first on
the continent to receive the technology to manufacture mRNA
vaccines at scale and according to international standards.
On Wednesday, Tedros said so far 20 countries had expressed
interest in getting training on developing an mRNA vaccine by
the South African hub.
(Reporting by Manojna Maddipatla in Bengaluru
Editing by Josephine Mason, Mark Potter and Tomasz Janowski)
[ad_2]
Source link
Trending Topics
Features
- Drive Toolkit
Download and distribute powerful vaccination QI resources for your community.
- Health Champions
Sign up now to support health equity and sustainable health outcomes in your community.
- Cancer Early Detection
MCED tests use a simple blood draw to screen for many kinds of cancer at once.
- PR
FYHN is a bridge connecting health information providers to BIPOC communities in a trusted environment.
- Medicare
Discover an honest look at our Medicare system.
- Alliance for Representative Clinical Trials
ARC was launched to create a network of community clinicians to diversify and bring clinical trials to communities of color and other communities that have been underrepresented.
- Reducing Patient Risk
The single most important purpose of our healthcare system is to reduce patient risk for an acute event.
- Jessica Wilson
- Victor Mejia
- Jessica Wilson


















